Reuters logo
BRIEF-Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in US
March 8, 2017 / 7:10 AM / in 9 months

BRIEF-Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in US

March 8 (Reuters) - Celyad SA:

* Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below